Alen Krajnc

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Journal of medicinal chemistry

ChemMedChem

Expert opinion on therapeutic patents

Cancer

Actelion Pharmaceuticals Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Actelion Pharmaceuticals Ltd Jan 08 2015 - Jul 31 2016

Switzerland

Trainee in Anti-Infectives (Synthetic medicinal chemistry) :: DD Chemistry

Publications

Katarina Grabrijan, Nika Strašek Benedik, Alen Krajnc, Krištof Bozovičar, Damijan Knez, Matic Proj, Irena Zdovc, Gobec Izidor Sosič, Carlos Contreras-Martel, Andrea Dessen, Martina Hrast Rambaher, Stanislav Gobec
Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s). Acta pharmaceutica (Zagreb, Croatia) 74 (3) (2024)
Alen Krajnc, Stanislav Gobec
Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393). Expert opinion on therapeutic patents (2023)
Hector Newman, Alen Krajnc, Dom Bellini, Charles J Eyermann, Grant A Boyle, Neil G Paterson, Katherine E McAuley, Robert Lesniak, Mukesh Gangar, Frank von Delft, Jürgen Brem, Kelly Chibale, Christopher J Schofield, Christopher G Dowson
High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes. Journal of medicinal chemistry 64 (15) (2021)
William D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, Yu Nakashima, Zhihong Zhang, James P Holt-Martyn, Alen Krajnc, Christopher J Schofield
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat. ChemMedChem 16 (13) (2021)
Urška Košir, Maria Loades, Jennifer Wild, Milan Wiedemann, Alen Krajnc, Sanja Roškar, Lucy Bowes
The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: Results from an online survey conducted in the early stages of the pandemic. Cancer 126 (19) (2020)
Anete Parkova, Anka Lucic, Alen Krajnc, Jürgen Brem, Karina Calvopiña, Gareth W Langley, Michael A McDonough, Peteris Trapencieris, Christopher J Schofield
Broad Spectrum β-Lactamase Inhibition by a Thioether Substituted Bicyclic Boronate. ACS infectious diseases 6 (6) (2020)
Pauline A Lang, Anete Parkova, Thomas M Leissing, Karina Calvopiña, Ricky Cain, Alen Krajnc, Tharindi D Panduwawala, Jules Philippe, Colin W G Fishwick, Peteris Trapencieris, Malcolm G P Page, Christopher J Schofield, Jürgen Brem
Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli. Biomolecules 10 (6) (2020)
Catherine L Tooke, Philip Hinchliffe, Alen Krajnc, Adrian J Mulholland, Jürgen Brem, Christopher J Schofield, James Spencer
Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition. RSC medicinal chemistry 11 (4) (2020)
Alen Krajnc, Jürgen Brem, Philip Hinchliffe, Karina Calvopiña, Tharindi D Panduwawala, Pauline A Lang, Jos J A G Kamps, Jonathan M Tyrrell, Emma Widlake, Benjamin G Saward, Timothy R Walsh, James Spencer, Christopher J Schofield
Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases. Journal of medicinal chemistry 62 (18) (2019)

Alen Krajnc.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alen Krajnc